share_log

Stephens & Co. Maintains Overweight on West Pharmaceutical Servs, Lowers Price Target to $390

Benzinga ·  Oct 27, 2023 11:32

Stephens & Co. analyst Jacob Johnson maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and lowers the price target from $420 to $390.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment